TY - JOUR T1 - Compound could help diabetic patients walk tightrope between heperglycemia, hypoglycemia JF - Canadian Medical Association Journal JO - CMAJ SP - 705 LP - 707 VL - 154 IS - 5 AU - F. Lowry Y1 - 1996/03/01 UR - http://www.cmaj.ca/content/154/5/705.abstract N2 - A pharmaceutical company is proceeding with clinical testing of a new compound that could make it easier for diabetic patients to maintain good control of blood-sugar levels. The compound, a peptide called amylin, appears to lessen wild fluctuations in blood-glucose levels by slowing the rate of gastric emptying and moderating the amount of postprandial glucose. Fran Lowry interviewed the researcher who discovered the peptide. ER -